Insider · CIK 0001976271
Colleen Corey
officer
Files at BIO (BIO-RAD LABORATORIES, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 6, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +576 | $0.00 | $0 | 19,759 | Sep 9, 2025 |
| Sep 6, 2025 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -209 | $295.43 | $62k | 19,550 | Sep 9, 2025 |
| Sep 5, 2025 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Restricted Stock Unitsderivative | +2,740 | $0.00 | $0 | 2,740 | Sep 9, 2025 |
| Sep 6, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -576 | $0.00 | $0 | 1,728 | Sep 9, 2025 |
| Sep 1, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Bio-Rad A Common Stock | +1,102 | $0.00 | $0 | 19,581 | Sep 3, 2025 |
| Sep 1, 2025 | BIO BIO-RAD LABORATORIES, INC. | FTax withholding Bio-Rad A Common Stock | -398 | $297.88 | $119k | 19,183 | Sep 3, 2025 |
| Sep 1, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -254 | $0.00 | $0 | 0 | Sep 3, 2025 |
| Sep 1, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -347 | $0.00 | $0 | 347 | Sep 3, 2025 |
| Sep 1, 2025 | BIO BIO-RAD LABORATORIES, INC. | MOption exercise Restricted Stock Unitsderivative | -501 | $0.00 | $0 | 1,002 | Sep 3, 2025 |
| Mar 3, 2025 | BIO BIO-RAD LABORATORIES, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +1,946 | $0.00 | $0 | 1,946 | Mar 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.